Physician profile
Elena Dyer
NPI 1871554279
$1,943.39
in general payments reported to CMS, 2019-2025
11 companies · $351 in 2025
The $351 reported for 2025 was more than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $665 · 2020: $318 · 2021: $158 · 2022: $327 · 2023: $124 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $475.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $574.80 | 2022-2025 | Ozempic, Wegovy |
| Amgen INC. | $328.52 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $188.43 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $124.63 | 2025 | Austedo Xr |
| Radius Health, INC. | $124.23 | 2019 | |
| Nevro Corp. | $115.57 | 2019 | |
| Advanced Accelerator Applications | $114.27 | 2020 | |
| Celgene Corporation | $107.58 | 2019 | |
| Daiichi Sankyo INC. | $103.79 | 2020 | |
| Karyopharm Therapeutics INC. | $102.72 | 2022 | |
| Stimwave Technologies Incorporated | $58.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elena Dyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.